| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/CLPT.1985.4 |
| P698 | PubMed publication ID | 3965234 |
| P2093 | author name string | C J Richardson | |
| R K Verbeeck | |||
| K L Blocka | |||
| S G Ross | |||
| P433 | issue | 1 | |
| P304 | page(s) | 13-18 | |
| P577 | publication date | 1985-01-01 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | Effects of age and sex on piroxicam disposition | |
| P478 | volume | 37 |
| Q36577155 | A Review of Fatalities Reported as Associated with NSAID Treatment in Ontario. |
| Q33882639 | Age-related changes in protein binding of drugs: implications for therapy |
| Q33937522 | Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach |
| Q40730345 | Clinical pharmacokinetics of tenoxicam |
| Q33765081 | Comparison of piroxicam pharmacokinetics and anti-inflammatory effect in rats after intra-articular and intramuscular administration |
| Q40834286 | Drug dosage in the elderly. Is it rational? |
| Q33563274 | Drugs and the elderly |
| Q40501559 | Effect of gonadectomy and hormones on sex differences in ketoprofen enantiomer glucuronidation and renal excretion of formed glucuronides in the rat. |
| Q44576033 | Endogenous and exogenous factors modifying the activity of human liver cytochrome P-450 enzymes |
| Q37262878 | Feline drug metabolism and disposition: pharmacokinetic evidence for species differences and molecular mechanisms |
| Q34768828 | Free drug metabolic clearance in elderly people. |
| Q41138044 | Gender differences in pharmacokinetics |
| Q40923059 | Gender effects in pharmacokinetics and pharmacodynamics |
| Q38018026 | Hepatic drug metabolism and aging |
| Q69664592 | High-performance liquid chromatographic analysis of piroxicam and its major metabolite 5'-hydroxypiroxicam in human plasma and urine |
| Q38165145 | Hormonal regulation of hepatic drug biotransformation and transport systems |
| Q68506534 | Nonsteroidal anti-inflammatory drugs |
| Q40754162 | Nonsteroidal anti-inflammatory drugs. Differential use in older patients |
| Q39560493 | Novel non-steroidal anti-inflammatory drugs |
| Q72281598 | Oral bioavailability of CHF1194, an inclusion complex of piroxicam and beta-cyclodextrin, in healthy subjects under single dose and steady-state conditions |
| Q69316438 | Pharmacokinetics of naproxen in elderly patients |
| Q34339828 | Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents |
| Q69021354 | Piroxicam and 5'-hydroxypiroxicam kinetics following multiple dose administration of piroxicam |
| Q68915989 | Piroxicam and naproxen plasma concentrations in patients with osteoarthritis: relation to age, sex, efficacy and adverse events |
| Q39757956 | Plasma protein binding of drugs in the elderly |
| Q44728643 | Plasma tenoxicam concentrations after single and multiple oral doses |
| Q40816610 | Rheumatoid arthritis in the aged. Incidence and optimal management |
| Q40919271 | Selective inhibitors of cyclooxygenase-2. Potential in elderly patients |
| Q35803732 | Sex and age differences in the pharmacokinetics of alosetron |
| Q77762657 | Simultaneous analysis of 14 non-steroidal anti-inflammatory drugs in human serum by electrospray ionization-tandem mass spectrometry without chromatography |
| Q44758593 | Single and multiple dose pharmacokinetics of a new NSAID (droxicam) in healthy volunteers |
| Q40536173 | Tenoxicam and renal function |
| Q34345908 | The pharmacokinetics of piroxicam in elderly persons with and without renal impairment |
| Q41526041 | Toxicity of Nonsteroidal Anti-Inflammatory Drugs in the Elderly: Is Advanced Age a Risk Factor? |
Search more.